Form 4: TheRealReal Director Caretha Coleman Reports Stock Award
SEC Form 4 Filing
Caretha Coleman, a director of TheRealReal, Inc., reported the acquisition of 50,925 shares of common stock on July 24, 2024, as part of a restricted stock unit award.
Summary
- On July 24, 2024, Caretha Coleman, a director at TheRealReal, Inc., acquired 50,925 shares of common stock.
- This acquisition was part of a restricted stock unit (RSU) award.
- The price per share for the acquisition was $0.0.
- Following the reported transaction, Coleman beneficially owns 225,758 shares.
- The RSUs vest on the earlier of the first anniversary of the grant date or the date immediately preceding the next annual meeting of the company's stockholders, contingent upon continued service as a non-employee director.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard transaction related to executive compensation. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.
Future Outlook
The vesting of the RSUs is contingent upon continued service as a non-employee director, suggesting an ongoing commitment to the company.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider ownership.
Key Dates
| Date | Description |
|---|---|
| 07/24/2024 | Date of transaction: Acquisition of common stock. |
| 07/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.